autoimmune disease

Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection

Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection

A consistent group of subjects with autoimmune diabetes (AD) is affected by a slowly progressive form of the disease, known as Latent Autoimmune Diabetes in Adults (LADA). This suggests that progression towards absolute insulin deficiency is not ineluctable. We hypothesize that LADA may offer a novel model to search for endogenous disease modifiers.

Autoimmune diseases and their manifestations on oral cavity: diagnosis and clinical management

Oral signs are frequently the first manifestation of autoimmune diseases. For this reason, dentists play an important role in the detection of emerging autoimmune pathologies. Indeed, an early diagnosis can play a decisive role in improving the quality of treatment strategies as well as quality of life. This can be obtained thanks to specific knowledge of oral manifestations of autoimmune diseases.

SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets

Background: Severe coronavirus disease 2019 (COVID-19) is associated with multiple comorbidities and is characterized by an auto-aggressive inflammatory state leading to massive collateral damage. To identify preventive and therapeutic strategies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is important to ascertain the molecular interactions between virus and host, and how they translate into disease pathophysiology.

Giant cell arteritis (GCA): pathogenesis, clinical aspects and treatment approaches

Giant Cell Arteritis (GCA), or Horton’s Arteritis, is a chronic form of vasculitis of the large and medium vessels, especially involving the extracranial branches of the carotid arteries, in particular, the temporal artery, with the involvement of the axillary, femoral and iliac arteries too. Arterial wall inflammation leads to luminal occlusion and tissue ischemia, which is responsible for the clinical manifestations of the disease.

Ocular mucous membrane pemphigoid: a review

Ocular mucous membrane pemphigoid (MMP) is a rare, immuno-mediated chronic progressive condition of the conjunctiva characterized by blisters developing from sub-epithelial tissue through disruption of the adhesions between the conjunctival epithelium and the sub-epithelium. Patients with ocular MMP, in many cases, develop profound conjunctival scarring and visual impairment. Furthermore, ocular MMP may lead to a progressive secondary corneal vascularization and to corneal opacification.

Otorhinolaryngological manifestations in sjogren syndrome

Background: Sjögren’s Syndrome (SS) is the second most common autoimmune rheumatic disease after rheumatoid arthritis and affects approximately 1 to 3% of the population. Most patients affected by Sjögren’s syndrome manifest otorhinolaryngological involvement, such as glandular, ocular, oral, otological, pharyngeal, laryngeal and sinonasal symptoms. Objective: The aim of this article is to emphasize the otorhinolaryngological manifestations of SS.

Pharmacological applications of Nrf2 inhibitors as potential antineoplastic drugs

Oxidative stress (OS) is associated with many diseases ranging from cancer to neurodegenerative disorders. Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) is one of the most effective cytoprotective controller against OS. Modulation of Nrf2 pathway constitutes a remarkable strategy in the antineoplastic treatments. A big number of Nrf2-antioxidant response element activators have been screened for use as chemo-preventive drugs in OS associated diseases like cancer even though activation of Nrf2 happens in a variety of cancers.

HLA Class I or Class II and Disease Association: Catch the Difference if You Can

The association of autoimmune diseases with HLA has been known for many decades. To date, however, the underlying mechanisms have not been fully understood.
The recently introduced genome-wide association studies (GWAS) have suggested that several genes converging in common pathways contribute to the genetic susceptibility in such disorders. Nevertheless, for most autoimmune/autoinflammatory diseases, the HLA genes are by far the strongest risk factors. The basis of some associations has now been elucidated, particularly in those cases in which exogenous factors are involved.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma